Hidropneumotórax espontâneo: manifestação inicial rara do mesotelioma pleural
Palavras-chave:
Hidropneumotórax, pleura, mesotelioma, asbestose, amiantoResumo
O mesotelioma maligno é uma neoplasia invariavelmente fatal
de células mesoteliais pleurais, peritoneais, pericárdicas ou da
túnica vaginalis. Estima-se que representem menos de 1% de
todas as neoplasias e a sua incidência tem vindo a aumentar
nos últimos anos. A apresentação clínica mais frequente é a dor
torácica associada a dispneia e derrame pleural recidivante, de
difícil resolução. Os autores apresentam um caso clínico de um
homem de 80 anos com um hidropneumotórax, cuja investigação
culminou com o diagnóstico de mesotelioma maligno.
Downloads
Referências
Antman KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993; 103:373S.
Pisani RJ, Colby TV, Williams DE. Malignant mesothelioma of the pleura. Mayo Clin Proc 1988; 63:1234.
Hodgson JT, McElvenny DM, Darnton AJ et al. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005; 92:587.
Murray R. Asbestos: a chronology of its origins and health effects. B J Ind Med 1990; 47:361-365.
Hansen J, de Klerk NH, Musk AW, Hobbs MST. Environmental exposure to crocidolite and mesothelioma. Exposure-response relationships. Am J Respir Crit Care Med 1998; 157:69.
Pira E, Pelucchi C, Buffoni L et al. Cancer mortality in a cohort of asbestos textile workers. Br J Cancer 2005; 92:580.
Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 2007; 18:985.
Tward JD, Wendland MM, Shrieve DC et al. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer 2006; 107:108.
Teta MJ, Lau E, Sceurman BK, Wagner ME. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer 2007; 109:1432.
De Luca A, Baldi A, Esposito V et al. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med 1997; 3:913.
McLaren BR, Haenel T, Stevenson S et al. Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomas. Aust N Z J Med 2000; 30:450.
Carbone M, Pass HI. Evolving aspects of mesothelioma carcionogenesis: SV40 and genetic predisposition. J Thoracic Oncology 2006; 1:169.
Testa JR, Pass HI, Carbone M. Benign and malignant mesothelioma. In: Principles and Practice of Oncology, 6th Ed, 2001;1937.
Antman KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993; 103:373S.
Hillerdal G. Malignant mesothelioma 1982: Review of 4710 published cases. Br J Dis Chest 1983; 77:321.
Bueno R, Reblando J, Glickman J et al. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg 2005; 78:1774.
Boutin C, Rey F, Gouvernet J et al. Thoracoscopy in pleural malignant mesothelioma: A prospective study of 188 consecutive patients. Cancer 1993; 72:389.
Heelan RT, Rusch VW, Begg CB et al. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol 1999; 172:1039.
Marom EM, Erasmus JJ, Pass HI, Patz EF Jr. The role of imaging in malignant pleural mesothelioma. Semin Oncol 2002; 29:26.
Gulmez I, Kart L, Buyukoglan H et al. Evaluation of malignant mesothelioma in central Anatolia: a study of 67 cases. Can Respir J 2004; 11:287.
Attanoos RL, Dojcinov SD, Webb R, Gibbs AR. Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms. Histopathology 2000; 37:224.
Lucas DR, Pass HI, Madan SK et al. Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study. Histopathology 2003; 42:270.
Ong ST, Vogelzang NJ. Chemotherapy in malignant pleural mesothelioma: A review. J Clin Oncol 1996; 14:1007.
Antman KH. Natural history and epidemiology of malignant mesothelioma. Chest 1993; 103:373S.
Berghmans T, Paesmans M, Lalami Y et al. Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis. Lung Cancer 2002; 38:111.
Curran D, Sahmoud T et al. Prognostic Factors in Patients with Pleural Mesothelioma: The European Organization for Research and Treatment of Cancer Experience. J Clin Oncol 1998; 16:14.
Hasturk S, Hanta Ismail et al. Spontaneous hydropneumothorax: an unusual presentation of malignant pleural mesothelioma. Turkish Resp J 2002;3 (3):127-129
Ficheiros Adicionais
Publicado
Como Citar
Edição
Secção
Licença
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Direitos de Autor (c) 2023 Medicina Interna
Acesso livre